Vicore Pharma Holding AB
NASDAQ:VCREMedical - Pharmaceuticals
-$0.24 today
- Market cap
- $279.65M
- Beta
- 0.15
Volume 0.00M
Average 0.26M
VCRE Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Vicore Pharma Holding ABNASDAQ: VCRE
Total Assets · Q2 FY2026 · quarter ended Jun 2026
Total assets of SEK 95.91M in Q2 FY2026
Q2 FY2026 total assets was SEK 95.91M.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
SEK · from the balance sheet
- Latest · FY2025
- 1.22B SEK
- Year-over-year change
- —
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.22B | — |
Total Assets vs competitors
How VCRE compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Jun 2026 | $521.92M USD | +102.8% | +36.4% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 95.91M SEK | — | — |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — |
| Peer median (excluding VCRE) | — | +102.8% | +36.4% | |
Competitors are the stored peer set for VCRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vicore Pharma Holding AB
NASDAQ:VCRE
Intrinsic Alpha fair value
Locked
Current Price
$9.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.